<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-91e9c5c4=""><div class="content_outer_container" data-v-91e9c5c4=""><div class="share_preview_container" data-v-91e9c5c4=""><div class="dialog_list" data-v-91e9c5c4=""><div class="dialog_item" data-v-91e9c5c4=""><div class="dialog_question fir_dialog_question" data-v-91e9c5c4=""><div class="dialog_content" data-v-91e9c5c4=""><h1 class="fir_question_content" data-v-91e9c5c4="">
                                    How did THRD's EPS perform in Q4 2024?
                                </h1> <div class="user_slot" data-v-91e9c5c4=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-91e9c5c4=""> <span class="user_desction" data-v-91e9c5c4="">
                                        
                                        4/13/2025 05:42pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-91e9c5c4="">Third Harmonic Bio Inc (THRD) reported a quarterly adjusted loss of 48 cents per share for the quarter ended December 31, 2024. This indicates a negative earnings performance for the company in Q4 2024.</div> <div class="dialog_answer" data-v-91e9c5c4=""><div class="dialog_content" data-v-91e9c5c4=""> <div class="answer_robot" data-v-91e9c5c4=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/AIme.ae832fb.png" alt="robot" class="avatar" data-v-91e9c5c4=""> <div class="user_name" data-v-91e9c5c4=""></div></div> <div class="question_content" data-v-91e9c5c4=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-4e97ba8a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-4e97ba8a=""> <div class="recommend-part" data-v-7790c618="" data-v-4e97ba8a=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj){return {layout:"default",data:[{noData:c,currentQuestion:e,textDescription:C,comeFrom:"AInvestShareLink",events:[],answerSource:q}],fetch:{},error:g,state:{sharePreviewModule:{loadJgySuccess:h,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:1,agent_id:a,output_media_info:[],task_id:a,language:a,source:q,cache_builder:a,reply_action:"Answer",execute_mode:t,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did THRD's EPS perform in Q4 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did THRD's EPS perform in Q4 2024?\",\"user_id\":\"dp78812444\",\"user_name\":\"\",\"trace_id\":\"8be46c46-ea1b-43fe-b871-cf4eccdb4d93\",\"session_id\":\"8be46c46-ea1b-43fe-b871-cf4eccdb4d93\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"search",raw_data:{number:D,title:E,summary:F,full_summary:"Third Harmonic Bio Inc THRD reported a quarterly adjusted loss of 48 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -17 cents. The mean expectation of five analysts for the quarter was for a loss of 34 cents per share. Wall Street expected results to range from -43 cents to -25 cents per share. Reported revenue was zero; analysts expected zero. Third Harmonic Bio Inc's reported EPS for the quarter was a loss of 48 cents. The company reported a quarterly loss of $21.48 million. Third Harmonic Bio Inc shares had fallen by 65.7% this quarter. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 5.6% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" 3 \"hold\" and no \"sell\" or \"strong sell.\" The average consensus recommendation for the biotechnology & medical research peer group is also \"buy\" Wall Street's median 12-month price target for Third Harmonic Bio Inc is $5.25 This summary was machine generated from LSEG data March 27 at 01:29 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET, MISSED  Dec. 31 2024 -0.34 -0.48 Missed  Sep. 30 2024 -0.30 -0.33 Missed  Jun. 30 2024 -0.27 -0.26 Beat  Mar. 31 2024 -0.31 -0.20 Beat",url:G,image_url:a,video_url:a,publish_time:H,search_extra_info:{search_burial_info:{id:I,uid:u,ab:{scene_id:J,layer_exp:[{layer_id:K,exp_id:L}]}}},simhash:"4ee1d14dcbc3fe4f",msg_id:u}}],answer_chain_name:M,agent_mode:N,native_answer:a,come_from:a,text_answer:C,trace_id:i,cost:12109,event_names:a,question:e,fallback_type:O,input_type:"typewrite",fall_back_reason:{fall_back_type:O,risk_detail:{matched_words:[]}},session_id:i,first_return_cost:2055,cache_type:a,question_id:i,transfer_question:e,signal_type:"ON_COMPLETE",start_time:P,remote_svc:q,slots:[],answer_type:t,user_id:v,skill_name:w},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:v,question:e,source:q,raw_question:e,version:"3.4.1",action_name:w,nlu:{entity:[{type:Q,value:"THRD.O",market:R}]},deep_research:c,deep_thinking:c,agent_mode:N},extra:{}},{answer_path:j,section:{id:k,info_texts:["Thinking"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:j,section:{id:k,info_texts:["Querying Stock: THRD EPS in Q4 2024"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b,status:S},logs:[],extra:{action:"Querying Stock",action_input:"THRD EPS in Q4 2024",thought:"The user seeks to analyze THRD's EPS performance in Q4 2024. I should focus on its EPS data for Q4 2024. I will use FinQuery for the data."}},{answer_path:d,section:{id:x,info_texts:[],show_type:r,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:j,section:{id:k,info_texts:["Searching Web: Third Harmonic Bio EPS Q4 2024"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b,status:S},logs:[],extra:{action:"Searching Web",action_input:"Third Harmonic Bio EPS Q4 2024",thought:"I am unable to obtain THRD's EPS data for Q4 2024 using FinQuery, now I will try again using Search."}},{answer_path:d,section:{id:x,info_texts:[],show_type:r,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:x,info_texts:[],show_type:r,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:j,section:{id:k,info_texts:["Generating Answer"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:y,info_texts:[],show_type:z,voice_txt:"Third",text_answer:T,rich_text:T,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:z,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{url:G,image_url:a,video_url:a,title:E,summary:F,index:D,publish_time:H,search_id:I,search_uid:u,search_ab:{scene_id:J,layer_exp:[{layer_id:K,exp_id:L}]},jump_type:"normal"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:y,info_texts:[],show_type:z,voice_txt:". This",text_answer:U,rich_text:U,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"THRD",market_id:R,name:V,domain:Q},pos:h,section_id:y,txt:V,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:j,section:{id:k,info_texts:["Completed"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:m,query_text:m,trace_info:{item_id:"fa61520e11a1facb5378bde52d02120d",item_type:f,item_name:m,rec_info:W}},{display_text:n,query_text:n,trace_info:{item_id:"1bffff4473c00498c3ad4e3b616fbb6f",item_type:f,item_name:n,rec_info:X}},{display_text:o,query_text:o,trace_info:{item_id:"28d4e1720fd3c0a909bd3ee3fe490813",item_type:f,item_name:o,rec_info:Y}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:h,type:"1",display2:c,url:a}},request_config:[{source_type:Z,related_name:_}],puuid:A,tag:a,category:"custom",uuid:$}],global:{urp_static_data:[{name:_,value:{status_code:h,columns:[{type:p,index_name:aa,key:aa},{type:p,index_name:ab,key:ab},{type:p,index_name:ac,key:ac},{type:p,index_name:ad,key:ad},{type:p,index_name:ae,key:ae}],datas:[{send_text:m,item_type:f,rec_info:W,display_text:m,rec_reason:a},{send_text:n,item_type:f,rec_info:X,display_text:n,rec_reason:a},{send_text:o,item_type:f,rec_info:Y,display_text:o,rec_reason:a}],dataSize:Z,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:af,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:s,"min-height":"100%",position:ag,height:s},isMaterial:c,id:af,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:h,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:B,componentUuid:$,script:[{name:ah,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:B,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:B},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:s,position:ag,height:s},isMaterial:b,_id:19,id:ah,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:ai,voice_txt:a,tracking_info:{},uuid:A},order:{is_auto:c,render_for:ai,chart_type:"command",puuid:A}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:r,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:w,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:t,answer_chain_name:M},is_deep_research:c,deep_thinking:c,create_time:1744537364697},is_last:b}],questionItem:{data:{qStr:e,encodeFlag:c,imageData:g,docsData:[],quoteData:g},tplType:"question"},events:[],agentId:a}],userId:v,userName:a,startTime:P,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:g,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],traceTableData:g,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-thrds-eps-perform-in-q4-2024-1efb3b\u002F",config:{_app:{basePath:aj,assetsPath:aj,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer","How did THRD's EPS perform in Q4 2024?","llm_generated",null,0,"8be46c46-ea1b-43fe-b871-cf4eccdb4d93","progress\u002Fsearching_for",1000,"searching_for","What was the actual EPS for THRD in Q4 2024?","What were the key drivers of THRD's Q4 2024 EPS?","How did THRD's Q4 2024 EPS compare to analyst expectations?","STR","ths_ainvest_lite_web","signal","auto","agent","7d854cd566c648d","dp78812444","review stocks",999,2001,"rich_text","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Third Harmonic Bio Inc (THRD) reported a quarterly adjusted loss of 48 cents per share for the quarter ended December 31, 2024. This indicates a negative earnings performance for the company in Q4 2024.",2,"Third Harmonic Bio Inc reports results for the quarter ended December 31 - Earnings Summary","Third Harmonic Bio Inc THRD reported a quarterly adjusted loss of 48 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -17 cents. The mean expectation of five analysts for the quarter was for a loss of 34 cents per share. Wall ...","https:\u002F\u002Fwww.tradingview.com\u002Fnews\u002Freuters.com,2025:newsml_L5N3QA18T:0-third-harmonic-bio-inc-reports-results-for-the-quarter-ended-december-31-earnings-summary\u002F","2024-12-30","7d854cd566c648d_0","oeqxkhszf","oeqxkhszf_layer","base","agent_common_v2\nagent-summary","normal_agent","NONE",1744537352588,"stock","185","thinking","Third Harmonic Bio Inc (THRD) reported a quarterly adjusted loss of 48 cents per share for the quarter ended December 31, 2024[^2]",". This indicates a negative earnings performance for the company in Q4 2024.","Third Harmonic Bio","2+679_496_21_554+0+0+8be46c46-ea1b-43fe-b871-cf4eccdb4d93+fa61520e11a1facb5378bde52d02120d+llm_generated+aimeTagAnalysis+0+0.06423245370388031+1","2+679_496_21_554+0+0+8be46c46-ea1b-43fe-b871-cf4eccdb4d93+1bffff4473c00498c3ad4e3b616fbb6f+llm_generated+aimeTagAnalysis+0+0.03136574476957321+2","2+679_496_21_554+0+0+8be46c46-ea1b-43fe-b871-cf4eccdb4d93+28d4e1720fd3c0a909bd3ee3fe490813+llm_generated+aimeTagAnalysis+0+0.019557833671569824+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc","\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/195837b.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/e402278.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7c15041.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/69a864a.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/9579193.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/6726d3c.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/c69ce63.js" defer=""></script>